Latest Breaking News On - Lymphoma international prognosis index - Page 1 : comparemela.com

Chidamide plus R-CHOP has received approval from China’s NMPA for the management of diffuse large B-cell lymphoma.

Chipscreen biosciencesXianping luChina national medical products administrationLymphoma international prognosis indexData monitoring committeeNational medical products administrationIndependent data monitoring committeeLugano classificationDiffuse largeb cell lymphomaR chop